首页> 外国专利> INDUCED MALIGNANT STEM CELLS OR PRE-INDUCTION CANCER STEM CELLS CAPABLE OF SELF-REPLICATION OUTSIDE OF AN ORGANISM, PRODUCTION METHOD FOR SAME, AND PRACTICAL APPLICATION FOR SAME

INDUCED MALIGNANT STEM CELLS OR PRE-INDUCTION CANCER STEM CELLS CAPABLE OF SELF-REPLICATION OUTSIDE OF AN ORGANISM, PRODUCTION METHOD FOR SAME, AND PRACTICAL APPLICATION FOR SAME

机译:能在有机体内自我复制的恶性干细胞或诱导前癌干细胞,其制备方法,以及实际应用

摘要

The present invention provides an induced cancer cell capable of self-replication in vitro which is useful in cancer therapy research and the research for cancer-related drug discovery, processes for production thereof, cancer cells induced by the malignant cells, and applications of these cells.;The present invention provides an induced cancer stem cell capable of proliferation (self-replication) in vitro, wherein the induced cancer stem cell has the following two characteristics:(1) expressing the six genes (self-renewal related genes) POU5F1, NANOG, SOX2, ZFP42, LIN28, and TERT selected from a certain group of genes; and(2) having an aberration which is either (a) a mutation in an endogenous tumor suppressor gene or (b) increased expression of an endogenous cancer-related gene.
机译:本发明提供了一种能够在体外自我复制的诱导癌细胞,其可用于癌症治疗研究以及与癌症有关的药物发现,其生产方法,由恶性细胞诱导的癌细胞以及这些细胞的应用的研究。本发明提供了一种能够在体外增殖(自我复制)的诱导癌干细胞,其中所述诱导癌干细胞具有以下两个特征:(1)表达选自特定基因组的六个基因(自我更新相关基因)POU5F1,NANOG,SOX2,ZFP42,LIN28和TERT;和(2)畸变要么是(a)内源性肿瘤抑制基因的突变,要么是(b)内源性癌症相关基因的表达增加。

著录项

  • 公开/公告号EP2599860A1

    专利类型

  • 公开/公告日2013-06-05

    原文格式PDF

  • 申请/专利权人 NATIONAL CANCER CENTER;

    申请/专利号EP20110786682

  • 发明设计人 ISHIKAWA TETSUYA;

    申请日2011-05-25

  • 分类号C12N5/10;A01K67/027;A61K39;C12N15/09;C12Q1/02;G01N33/15;G01N33/50;

  • 国家 EP

  • 入库时间 2022-08-21 16:29:34

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号